Treatment consistency across levels of baseline renal function with Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban once-daily, oral, direct factor Xa inhibition compared with vitamin k antagonism for prevention of stroke and embolism trial in atrial fibrillation) analysis - Lindner, Samuel M.; Hacke, Werner (Circulation, 2017)
Gesehen am: 13.04.2017